Has Paige Leykam, APRN received payments from drug or device companies?

Yes. Drug and device makers reported $22,708 in general payments to Paige Leykam, APRN across 985 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Paige Leykam, APRN did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Paige Leykam, APRN come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Paige Leykam, APRN

Nurse Practitioner · Surprise, AZNPI 1033470968

Payments from drug & device makers

$22,708in general payments, 2019–2025

Across 985 payments — averaging $23.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$2K
AstraZeneca$2K
E.r. Squibb & Sons, L.L.C.$1K
Johnson & Johnson$1K
AbbVie$1K
Novartis$1K
plus $14K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen	71	$1,940
AstraZeneca(2 entities)	60	$1,701
E.r. Squibb & Sons, L.L.C.	82	$1,386
Johnson & Johnson(2 entities)	59	$1,321
AbbVie	66	$1,158
Novartis	58	$1,119
Pfizer	60	$1,112
Merck	37	$842
GSK	37	$703
Sanofi	28	$691
Seagen Inc.	18	$673
Lilly USA, LLC	30	$592
Incyte Corporation	25	$576
Daiichi Sankyo Inc.	23	$569
Astellas Pharma US Inc	12	$547
Sobi, Inc	23	$545
Bristol Myers Squibb	29	$537
AVEO Pharmaceuticals, Inc.	11	$347
UCB, Inc.	11	$343
Takeda Pharmaceuticals U.S.A., Inc.	10	$311
Genmab U.S., Inc.	7	$280
EMD Serono, Inc.	13	$270
Pharmacyclics LLC, An Abbvie Company	12	$268
Rigel Pharmaceuticals, Inc.	10	$263
Genentech USA, Inc.	10	$252
Jazz Pharmaceuticals Inc.	9	$242
Bayer	10	$236
Sumitomo Pharma America, Inc.	2	$201
Eisai Inc.	9	$197
Sanofi-aventis U.S. LLC	2	$185
Gilead(2 entities)	8	$177
Exelixis Inc.	7	$169
Array Biopharma Inc	9	$166
Ipsen Biopharmaceuticals, Inc	8	$165
Regeneron Healthcare Solutions, Inc.	5	$145
Pharmacosmos Therapeutics Inc.	7	$143
Servier Pharmaceuticals LLC	6	$131
Sun Pharmaceutical Industries Inc.	5	$119
Blueprint Medicines Corporation	5	$111
Radius Health, Inc.	5	$108
Stemline Therapeutics Inc.	4	$100
G1 Therapeutics, Inc.	4	$97
Beigene USA, Inc.	4	$81
Springworks Therapeutics, Inc.	3	$77
Menarini Silicon Biosystems, Inc.	2	$73
Adaptive Biotechnologies Corporation	4	$73
Kyowa Kirin, Inc.	3	$73
Boehringer Ingelheim	3	$72
Mirati Therapeutics, Inc.	4	$70
Pharmaessentia USA Corporation	4	$66
Octapharma USA, Inc.	2	$65
Karyopharm Therapeutics Inc.	4	$63
Tersera Therapeutics LLC	2	$63
Beone Medicines USA, Inc.	2	$61
Legend Biotech USA Inc.	3	$58
Tempus AI, Inc	3	$58
Organon	4	$45
Abbott	1	$44
Amneal Pharmaceuticals LLC	2	$44
Teva Pharmaceuticals USA, Inc.	3	$42

How this compares

$22,708 in reported general payments places this provider in the 95th percentile of 1,719 nurse practitioner providers in Arizona.

See all nurse practitioner providers in Arizona →

Medicare billing

Part B allowed, 2024

$90,376

Medicare patients

Services billed

7,560

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Surprise

Ann MooreGlendale$2.1M
Andrea KesslerLitchfield Park$780K
Sandra KurtinTucson$201K
Kristen HerzogScottsdale$162K
Krista ArredondoChandler$133K
Shannon MorgensternOro Valley$71K
Helena In't VeldPhoenix$64K
Steven KalfusChandler$43K
Dustin NickersonPhoenix$39K
Shannon BoffeliFlagstaff$31K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →